Smith & Nephew moves into FTSE big league:
This article was originally published in Clinica
The UK's largest device company Smith & Nephew has been inducted into the blue chip index of UK shares. It took its place in the FTSE 100 list last week. The move will attract institutional investors seeking to track the index. S&N is currently outperforming the FTSE 100. Based on prices a year ago, the index is down 10%, while S&N is up by 50%.